Highland Capital Management (Tennessee)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,382
| Closed | -$1.89M | – | 441 |
|
|
2025
Q4 | $1.89M | Sell |
15,382
-437
| -3% | -$53.1K | 0.09% | 173 |
|
|
2025
Q3 | $1.76M | Buy |
+15,819
| New | +$1.8M | 0.09% | 192 |
|
|
2022
Q1 | – | Sell |
-3,161
| Closed | -$230K | – | 341 |
|
|
2021
Q4 | $230K | Sell |
3,161
-1,491
| -32% | -$103K | 0.01% | 322 |
|
|
2021
Q3 | $325K | Sell |
4,652
-354
| -7% | -$24.9K | 0.02% | 305 |
|
|
2021
Q2 | $345K | Sell |
5,006
-75
| -1% | -$5.01K | 0.02% | 294 |
|
|
2021
Q1 | $328K | Sell |
5,081
-179
| -3% | -$11.5K | 0.02% | 300 |
|
|
2020
Q4 | $306K | Sell |
5,260
-1,186
| -18% | -$71.6K | 0.02% | 304 |
|
|
2020
Q3 | $407K | Sell |
6,446
-8,759
| -58% | -$607K | 0.03% | 264 |
|
|
2020
Q2 | $1.17M | Sell |
15,205
-69
| -0.5% | -$5.29K | 0.09% | 203 |
|
|
2020
Q1 | $1.14M | Sell |
15,274
-2,474
| -14% | -$171K | 0.11% | 180 |
|
|
2019
Q4 | $1.15M | Sell |
17,748
-3,897
| -18% | -$254K | 0.08% | 208 |
|
|
2019
Q3 | $1.37M | Sell |
21,645
-130
| -0.6% | -$8.5K | 0.1% | 198 |
|
|
2019
Q2 | $1.47M | Sell |
21,775
-13,738
| -39% | -$904K | 0.11% | 193 |
|
|
2019
Q1 | $2.31M | Buy |
35,513
+196
| +0.6% | +$13K | 0.18% | 135 |
|
|
2018
Q4 | $2.21M | Sell |
35,317
-3,053
| -8% | -$213K | 0.19% | 128 |
|
|
2018
Q3 | $2.96M | Sell |
38,370
-397
| -1% | -$30K | 0.21% | 126 |
|
|
2018
Q2 | $2.75M | Sell |
38,767
-617
| -2% | -$43.6K | 0.21% | 130 |
|
|
2018
Q1 | $2.97M | Buy |
39,384
+2,745
| +7% | +$218K | 0.23% | 120 |
|
|
2017
Q4 | $2.63M | Sell |
36,639
-1,733
| -5% | -$132K | 0.2% | 127 |
|
|
2017
Q3 | $3.11M | Sell |
38,372
-1,491
| -4% | -$114K | 0.25% | 117 |
|
|
2017
Q2 | $2.82M | Sell |
39,863
-439
| -1% | -$29.2K | 0.23% | 126 |
|
|
2017
Q1 | $2.74M | Sell |
40,302
-6,861
| -15% | -$482K | 0.23% | 123 |
|
|
2016
Q4 | $3.38M | Sell |
47,163
-32,416
| -41% | -$2.41M | 0.28% | 103 |
|
|
2016
Q3 | $6.3M | Sell |
79,579
-23,417
| -23% | -$1.9M | 0.53% | 58 |
|
|
2016
Q2 | $8.59M | Sell |
102,996
-1,134
| -1% | -$101K | 0.74% | 38 |
|
|
2016
Q1 | $9.56M | Sell |
104,130
-6,938
| -6% | -$626K | 0.82% | 34 |
|
|
2015
Q4 | $11.2M | Buy |
111,068
+5,736
| +5% | +$597K | 0.91% | 25 |
|
|
2015
Q3 | $10.3M | Buy |
105,332
+26,862
| +34% | +$2.98M | 0.87% | 26 |
|
|
2015
Q2 | $9.19M | Buy |
78,470
+31,006
| +65% | +$3.39M | 0.71% | 36 |
|
|
2015
Q1 | $4.66M | Buy |
47,464
+37,177
| +361% | +$3.78M | 0.91% | 40 |
|
|
2014
Q4 | $970K | Sell |
10,287
-29,602
| -74% | -$3.06M | 0.18% | 97 |
|
|
2014
Q3 | $4.25M | Buy |
39,889
+575
| +1% | +$56.3K | 0.83% | 44 |
|
|
2014
Q2 | $3.26M | Buy |
+39,314
| New | +$3.06M | 0.61% | 58 |
|
Other funds holding GILD
Highland Capital Management (Tennessee)'s GILD Position: Q1 2026 in Review
Highland Capital Management (Tennessee) sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 15,382 shares — an estimated $1.89M sold.
Highland Capital Management (Tennessee) first reported a position in GILD in Q2 2014 and held it in 33 quarters. The position peaked at $11.2M in Q4 2015. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Highland Capital Management (Tennessee) reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Highland Capital Management (Tennessee) sold 15,382 Gilead Sciences shares in Q1 2026, an estimated $1.89M.
- Highland Capital Management (Tennessee) first reported a position in Gilead Sciences in Q2 2014 and held it in 33 quarters.
- Highland Capital Management (Tennessee)'s Gilead Sciences position peaked at $11.2M in Q4 2015.
- 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2026, filed 13 Apr 2026.